Lopinavir
What's New
Last Posted: Feb 16, 2021
- Pharmacogenomics of COVID-19 therapies.
Takahashi Takuto et al. NPJ genomic medicine 2020 Aug 5(1) 35 - Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations.
Stankovic Biljana, et al. Journal of medical biochemistry 2020 10 (4) 488-499 - Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results
WHO Solidarity Trial Consortium, MEDRXIV, October 15, 2020 - Pharmacogenomics of COVID-19 therapies
T Takahashi et al, NPJ Genomic Medicine, August 18, 2020 - Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients.
Rungtivasuwan Kanokrat, et al. Pharmacogenomics 2017 11 (16) 1481-1490 - Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine.
Green Bruce, et al. Clinical pharmacokinetics 2017 0 (5) 525-536 - Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.
Mpeta Bafokeng, et al. Pharmacogenomics 2016 0 (7) 679-90 - Contribution of genetic background and clinical D:A:D risk score to chronic kidney disease in Swiss HIV-positive persons with normal baseline estimated glomerular filtration rate.
Dietrich Léna G, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019 4 - Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients.
López Aspiroz Elena, et al. Personalized medicine 2014 9 (7) 693-704 - Impact of Single Nucleotide Polymorphisms on Plasma Concentrations of Efavirenz and Lopinavir/ritonavir in Chinese Children Infected with the Human Immunodeficiency Virus.
Liu Xia, et al. Pharmacotherapy 2017 7
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source: